Internal Medicine, Rheumatology · Baytown, TX
NPI
1124222708
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1610 W Baker Rd Ste C
Baytown, TX, 77521
Phone (281) 422-7179
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.2M
269,194 services
Medicare patients, 2024
581
Average age 73
Drug cost, 2024
$6.1M
7,436 prescriptions
Company payments, 2025
$2,185
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sabeen Najam was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 157,000 times for 48 patients. In total Sabeen Najam billed 269,194 services in 39 codes, and Medicare paid $2.2M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-30.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 157,000 | 48 | $3.57 | $561K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 26,060 | 31 | $9.11 | $237K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 15,875 | 22 | $33.87 | $538K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 7,980 | 11 | $8.66 | $69K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 5,200 | 50 | $0.10 | $528 |
| J0897 Injection, denosumab, 1 mg | Office | 5,101 | 54 | $20.14 | $103K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,919 | 36 | $0.22 | $431 |
| 99214 Office E&M - Established | Office | 1,212 | 540 | $90.87 | $110K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 967 | 493 | $12.53 | $12K |
| 96401 Chemotherapy Administration | Office | 964 | 114 | $55.55 | $54K |
| 96413 Chemotherapy Administration | Office | 582 | 87 | $99.35 | $58K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 236 | 55 | $0.67 | $157 |
| 99204 Office E&M - New | Office | 144 | 144 | $115.27 | $17K |
| 96415 Chemotherapy Administration | Office | 100 | 17 | $21.41 | $2,141 |
| 96372 Injection Administration | Office | 91 | 70 | $10.34 | $941 |
By year: 2022 $2.4M for 263,074 services; 2023 $2.3M for 269,787 services; 2024 $2.2M for 269,194 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sabeen Najam prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,127 prescriptions and refills. In total Sabeen Najam wrote 7,436 Medicare prescriptions that cost $6.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,127 | 2,148 | 364 | $31K |
| Prednisone Generic | 687 | 1,001 | 216 | $3,326 |
| Gabapentin Generic | 662 | 1,140 | 216 | $8,041 |
| Methotrexate Methotrexate Sodium | 656 | 1,214 | 190 | $10K |
| Pregabalin Generic | 389 | 501 | 100 | $6,959 |
| Celecoxib Generic | 327 | 415 | 115 | $9,751 |
| Meloxicam Generic | 317 | 475 | 131 | $1,023 |
| Duloxetine Hcl Generic | 269 | 503 | 73 | $4,352 |
| Tramadol Hcl Generic | 234 | 249 | 49 | $1,440 |
| Tizanidine Hcl Generic | 180 | 326 | 55 | $1,442 |
| Diclofenac Sodium Generic | 159 | 243 | 60 | $2,397 |
| Methylprednisolone Generic | 141 | 153 | 97 | $961 |
| Folic Acid Generic | 128 | 252 | 40 | $922 |
| Leflunomide Generic | 107 | 201 | 36 | $3,290 |
| Sulfasalazine Generic | 107 | 189 | 40 | $1,847 |
Brand drugs: 1,006 claims; generic drugs: 6,430 claims; opioid claims: 320.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sabeen Najam $2,185 ($2,185 in general payments such as food, travel and fees) from 26 companies. The largest payer was Amgen Inc. with $439.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 27 | $439 |
| ANI Pharmaceuticals, Inc. ANIP | 14 | $245 |
| Mallinckrodt Hospital Products Inc. | 10 | $236 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $181 |
| UCB, Inc. UCB.BR | 5 | $156 |
| Janssen Biotech, Inc. JNJ | 4 | $146 |
| Fresenius Kabi USA, LLC | 5 | $123 |
| Abbvie Inc. ABBV | 6 | $114 |
| Pfizer Inc. PFE | 4 | $114 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $98.62 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.